Evidence map›Paper›PMID 30013081›Full record

ArticleNature communications2018

ZNF506-dependent positive feedback loop regulates H2AX signaling after DNA damage.

Somaira Nowsheen, Khaled Aziz, Kuntian Luo, Min Deng, Bo Qin, Jian Yuan, Karthik B Jeganathan, Jia Yu, Henan Zhang, Wei Ding and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The multi-functional eyes absent proteins.Critical reviews in biochemistry and molecular biology · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Somaira NowsheenMayo Clinic Medical Scientist Training Program, Mayo Clinic School of Medicine and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-7174-5366
Khaled AzizMayo Clinic Medical Scientist Training Program, Mayo Clinic School of Medicine and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
Kuntian LuoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Min DengDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Bo QinDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Jian YuanDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Karthik B JeganathanDepartment of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Jia YuDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Henan ZhangDepartment of Hematology, Mayo Clinic, Rochester, MN, 55905, USA.
Wei DingDepartment of Hematology, Mayo Clinic, Rochester, MN, 55905, USA.
Jan M van DeursenDepartment of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Zhenkun LouDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA. lou.zhenkun@mayo.edu.ORCID http://orcid.org/0000-0003-1938-3091
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USTongji University · CN

Funding

Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
Regulation of homologous recombination and cancer cell response to chemoradiotherapyR01CA203561 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2016 to 2020
$1.8M
Deubiquitinases in regulation of BRCA1 pathwayR01CA203971 · NCI · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, LOU, ZHENKUN · 2016 to 2020
$1.8M
The Role of WSB1 in TumorigenesisR01CA189666 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA189666NCI NIH HHS R01 CA203561NCI NIH HHS R01 CA203971U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA130996U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA189666U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA203561
6 · The paper itself

Abstract

Cells respond to cytotoxic DNA double-strand breaks by recruiting repair proteins to the damaged site. Phosphorylation of the histone variant H2AX at S139 and Y142 modulate its interaction with downstream DNA repair proteins and their recruitment to DNA lesions. Here we report ATM-dependent ZNF506 localization to the lesion through MDC1 following DNA damage. ZNF506, in turn, recruits the protein phosphatase EYA, resulting in dephosphorylation of H2AX at Y142, which further facilitates the recruitment of MDC1 and other downstream repair factors. Thus, ZNF506 regulates the early dynamic signaling in the DNA damage response (DDR) pathway and controls progressive downstream signal amplification. Cells lacking ZNF506 or harboring mutations found in cancer patient samples are more sensitive to radiation, offering a potential new therapeutic option for cancers with mutations in this pathway. Taken together, these results demonstrate how the DDR pathway is orchestrated by ZNF506 to maintain genomic integrity.

Indexed as

DNA RepairFeedback, PhysiologicalGene Expression Regulation, LeukemicAdaptor Proteins, Signal TransducingAnimalsB-LymphocytesCell Cycle ProteinsCell Line, TumorDNA DamageEpithelial CellsHEK293 CellsHistonesHumansIntracellular Signaling Peptides and ProteinsKruppel-Like Transcription FactorsLeukemia, Prolymphocytic, T-CellAdaptor Proteins, Signal TransducingCell Cycle ProteinsEYA1 protein, humanH2AX protein, humanHistonesIntracellular Signaling Peptides and ProteinsKruppel-Like Transcription FactorsMDC1 protein, humanNuclear ProteinsProtein Tyrosine PhosphatasesRecombinant ProteinsRepressor ProteinsTrans-ActivatorsZNF506 protein, human

Identifiers

PMID30013081
PMCPMC6048040
OpenAlexW2867588383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.